CA
IDYA icon

Continuum Advisory’s IDEAYA Biosciences IDYA Stock Holding History

Continuum Advisory’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69
Closed -$1.13K – 942
2025
Q1 		$1.13K Buy
69
+1
+1% +$21 ﹤0.01% 1488
2024
Q4 		$1.75K Hold
68
– – ﹤0.01% 1459
2024
Q3 		$2K Buy
68
+32
+89% +$1.21K ﹤0.01% 1428
2024
Q2 		$1.26K Buy
36
+8
+29% +$317 ﹤0.01% 1423
2024
Q1 		$1.14K Buy
+28
New +$1.2K ﹤0.01% 1443

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Continuum Advisory's IDYA Position: Q2 2025 in Review

Continuum Advisory sold out of IDEAYA Biosciences (IDYA) in Q2 2025, closing a stake of 69 shares — an estimated $1.13K sold.

Continuum Advisory first reported a position in IDYA in Q1 2024 and held it in 5 quarters. The position peaked at $2K in Q3 2024. 204 funds tracked by Wall St. Rank hold IDYA as of Q2 2025.

  • Continuum Advisory reported no remaining IDEAYA Biosciences position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 69 IDEAYA Biosciences shares in Q2 2025, an estimated $1.13K.
  • Continuum Advisory first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's IDEAYA Biosciences position peaked at $2K in Q3 2024.
  • 204 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.